- Home
- CSTM
as of 03-12-2026 3:44pm EST
Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.
| Founded: | 2010 | Country: | France |
| Employees: | 11500 | City: | PARIS |
| Market Cap: | 3.4B | IPO Year: | 2012 |
| Target Price: | $29.00 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.92 | EPS Growth: | 405.26 |
| 52 Week Low/High: | $7.33 - $27.41 | Next Earning Date: | 05-19-2026 |
| Revenue: | $8,449,000,000 | Revenue Growth: | 15.19% |
| Revenue Growth (this year): | 21.45% | Revenue Growth (next year): | 0.62% |
| P/E Ratio: | 13.19 | Index: | N/A |
| Free Cash Flow: | 159.0M | FCF Growth: | N/A |
Stock Insider Trading Activity of Constellium SE (France) (CSTM)
SVP CPO
Avg Cost/Share
$25.87
Shares
1,113
Total Value
$28,793.31
Owned After
33,237
SEC Form 4
President, AS&I
Avg Cost/Share
$25.89
Shares
1,500
Total Value
$38,835.00
Owned After
65,020
SEC Form 4
President, A&T
Avg Cost/Share
$25.87
Shares
4,728
Total Value
$122,313.36
Owned After
182,120
SEC Form 4
CEO
Avg Cost/Share
$25.87
Shares
4,614
Total Value
$119,364.18
Owned After
378,090
SEC Form 4
EVP & CFO
Avg Cost/Share
$25.87
Shares
41,717
Total Value
$1,079,218.79
Owned After
190,879
SEC Form 4
SVP & CHRO
Avg Cost/Share
$25.87
Shares
29,900
Total Value
$773,513.00
Owned After
210,723
SEC Form 4
SVP CPO
Avg Cost/Share
$0.00
Shares
14,592
Total Value
$0.00
Owned After
34,350
SEC Form 4
President, AS&I
Avg Cost/Share
$0.00
Shares
8,026
Total Value
$0.00
Owned After
66,520
SEC Form 4
President, A&T
Avg Cost/Share
$0.00
Shares
71,132
Total Value
$0.00
Owned After
186,848
SEC Form 4
SVP PA, Comm & Sust
Avg Cost/Share
$24.67
Shares
17,701
Total Value
$436,683.67
Owned After
103,466
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Becker Marcus | CSTM | SVP CPO | Mar 10, 2026 | Sell | $25.87 | 1,113 | $28,793.31 | 33,237 | |
| Corre Stephane | CSTM | President, AS&I | Mar 10, 2026 | Sell | $25.89 | 1,500 | $38,835.00 | 65,020 | |
| Hoffmann Philippe | CSTM | President, A&T | Mar 10, 2026 | Sell | $25.87 | 4,728 | $122,313.36 | 182,120 | |
| Joerg Ingrid | CSTM | CEO | Mar 10, 2026 | Sell | $25.87 | 4,614 | $119,364.18 | 378,090 | |
| Guo Jack Q. | CSTM | EVP & CFO | Mar 10, 2026 | Sell | $25.87 | 41,717 | $1,079,218.79 | 190,879 | |
| Jurkovic Philip Ryan | CSTM | SVP & CHRO | Mar 10, 2026 | Sell | $25.87 | 29,900 | $773,513.00 | 210,723 | |
| Becker Marcus | CSTM | SVP CPO | Mar 9, 2026 | Buy | $0.00 | 14,592 | $0.00 | 34,350 | |
| Corre Stephane | CSTM | President, AS&I | Mar 9, 2026 | Buy | $0.00 | 8,026 | $0.00 | 66,520 | |
| Hoffmann Philippe | CSTM | President, A&T | Mar 9, 2026 | Buy | $0.00 | 71,132 | $0.00 | 186,848 | |
| Brun Nicolas | CSTM | SVP PA, Comm & Sust | Mar 9, 2026 | Sell | $24.67 | 17,701 | $436,683.67 | 103,466 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 18, 2026 · 100% conf.
Q4 2025 Earnings
8-K SELLFeb 18, 2026 · 100% conf.
1D
+0.03%
$25.65
5D
-5.35%
$24.27
20D
+0.57%
$25.79
cstm-20260218false000156341100015634112026-02-182026-02-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 18, 2026
Constellium SE (Exact name of registrant as specified in its charter)
France001-3593198-0667516 (State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
300 East Lombard Street, Suite 1710 Baltimore,
MD21202
(Address of principal executive office (US))
(443) 420-7861 (Registrant's telephone number, including area code)
N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act Title of each classTrading Symbol(s)Name of each exchange on which registered Ordinary Shares CSTMNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in [sic] Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On February 18, 2026, Constellium SE (the “Company”) issued a press release announcing its financial results for the fourth quarter of 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The Company is also furnishing an investor presentation relating to its fourth quarter of 2025 (the “Presentation”), which will be used by the management team for presentations to investors and others. A copy of the Presentation is attached hereto as Exhibit 99.2 and incorporated into this Item 2.02 by reference. The Presentation is also available on the Company’s web site at www.constellium.com. In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits The following exhibits are furnished with this report on Form 8-K:
Exhibit No. Description
99.1 Press Release by Constellium SE dated February 18, 2026
99.2 Investor Presentation 104The cover page of this Current Report on Form 8-K, formatted in Inline XBRL
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CONSTELLIUM SE
(Registrant)
February 18, 2026 By:/s/ Jack Guo Name:Jack Guo Title:Executive Vice President & Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 29, 2025
Q3 2025 Earnings
8-KOct 29, 2025
cstm-20251029false000156341100015634112025-10-292025-10-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 29, 2025
Constellium SE (Exact name of registrant as specified in its charter)
France001-3593198-0667516 (State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
300 East Lombard Street, Suite 1710 Baltimore,
MD21202
(Address of principal executive office (US))
(443) 420-7861 (Registrant's telephone number, including area code)
N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act Title of each classTrading Symbol(s)Name of each exchange on which registered Ordinary Shares CSTMNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in [sic] Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02Results of Operations and Financial Condition
On October 29, 2025, Constellium SE (the “Company”) issued a press release announcing its financial results for the third quarter of 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The Company is also furnishing an investor presentation relating to its third quarter of 2025 (the “Presentation”), which will be used by the management team for presentations to investors and others. A copy of the Presentation is attached hereto as Exhibit 99.2 and incorporated into this Item 2.02 by reference. The Presentation is also available on the Company’s web site at www.constellium.com. In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01Financial Statements and Exhibits
(d) Exhibits The following exhibits are furnished with this report on Form 8-K:
Exhibit No. Description
99.1 Press Release by Constellium SE dated October 29, 2025
99.2 Investor Presentation 104The cover page of this Current Report on Form 8-K, formatted in Inline XBRL
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CONSTELLIUM SE
(Registrant)
October 29, 2025 By:/s/ Jack Guo Name:Jack Guo Title:Executive Vice President & Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Jul 29, 2025
Q2 2025 Earnings
8-KJul 29, 2025
false000156341100015634112025-07-292025-07-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 29, 2025
Constellium SE
(Exact name of registrant as specified in its charter)
France
001-35931
98-0667516
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
300 East Lombard Street
Suite 1710
Baltimore, MD 21202
United States
(Address of principal executive office (US))
(443) 420-7861
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Ordinary Shares
CSTM
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in [sic] Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition
On July 29, 2025, Constellium SE (the “Company”) issued a press release announcing its financial results for the second quarter of 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The Company is also furnishing an investor presentation relating to its second quarter of 2025 (the “Presentation”), which will be used by the management team for presentations to investors and others. A copy of the Presentation is attached hereto as Exhibit 99.2 and incorporated into this Item 2.02 by reference. The Presentation is also available on the Company’s web site at www.constellium.com.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01.
Financial Statements and Exhibits
(d) Exhibits
The following exhibits are furnished with this report on Form 8-K:
Exhibit
No.
Description
99.1
Press Release by Constellium SE dated July 29, 2025
99.2
Investor Presentation
104
The cover page of this Current Report on Form 8-K, formatted in Inline XBRL
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CONSTELLIUM SE
(Registrant)
July 29, 2025
By:
/s/ Jack Guo
Name:
Jack Guo
Title:
Executive Vice President & Chief Financial Officer
2025 Q1 Q1 2025 Earnings
8-K Apr 30, 2025
Q1 2025 Earnings
8-KApr 30, 2025
false000156341100015634112025-04-302025-04-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 30, 2025
Constellium SE
(Exact name of registrant as specified in its charter)
France
001-35931
98-0667516
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
300 East Lombard Street
Suite 1710
Baltimore, MD 21202
United States
(Address of principal executive office (US))
(443) 420-7861
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Ordinary Shares
CSTM
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in [sic] Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition
On April 30, 2025, Constellium SE (the “Company”) issued a press release announcing its financial results for the first quarter of 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The Company is also furnishing an investor presentation relating to its first quarter of 2025 (the “Presentation”), which will be used by the management team for
presentations to investors and others. A copy of the Presentation is attached hereto as Exhibit 99.2 and incorporated into this Item 2.02 by reference. The Presentation is also available on the Company’s web site at www.constellium.com.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01.
Financial Statements and Exhibits
(d) Exhibits
The following exhibits are furnished with this report on Form 8-K:
Exhibit No.
Description
99.1
Press Release by Constellium SE dated April 30, 2025
99.2
Investor Presentation
104
The cover page of this Current Report on Form 8-K, formatted in Inline XBRL
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CONSTELLIUM SE
(Registrant)
April 30, 2025
By:
/s/ Jack Guo
Name:
Jack Guo
Title:
Chief Financial Officer
2024 Q4 Q4 2024 Earnings
8-K Feb 20, 2025
Q4 2024 Earnings
8-KFeb 20, 2025
8-K 1 ef20043881_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 20, 2025
Constellium SE
(Exact name of registrant as specified in its charter)
France
001-35931
Not Applicable
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
300 East Lombard Street
Suite 1710
Baltimore, MD 21202
United States
(Address of principal executive office (US))
(443) 420-7861
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Ordinary Shares
CSTM
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in [sic] Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition
On February 20, 2025, Constellium SE (the “Company”) issued a press release announcing its financial results for the fourth quarter of 2024 and full year 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The Company is also furnishing an investor presentation relating to its fourth quarter of 2024 (the “Presentation”), which will be used by the management team for presentations to investors and others. A copy of the Presentation is attached hereto as Exhibit 99.2 and incorporated herein by reference. The Presentation is also available on the Company’s website at www.constellium.com.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01.
Financial Statements and Exhibits
(d) Exhibits
The following exhibits are furnished with this report on Form 8-K:
Exhibit No.
Description
99.1
Press Release by Constellium SE dated February 20, 2025
99.2
Investor Presentation
104
The cover page of this Current Report on Form 8-K, formatted in Inline XBRL
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CONSTELLIUM SE
(Registrant)
February 20, 2025
By:
/s/ Jack Guo
Name:
Jack Guo
Title:
Chief Financial Officer
Compare CSTM vs Leading Stocks
See how CSTM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CSTM Constellium SE (France) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.